Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2,927 | $1,075 | $1,445 | $3,130 |
| - Cash | $1,023 | $1,140 | $1,339 | $1,461 |
| + Debt | $271 | $300 | $272 | $168 |
| Enterprise Value | $2,175 | $236 | $379 | $1,837 |
| Revenue | $217 | $153 | $103 | $6 |
| % Growth | 41.9% | 49.3% | 1,535% | – |
| Gross Profit | $118 | $77 | $48 | -$7 |
| % Margin | 54.2% | 50.2% | 46.5% | -106.3% |
| EBITDA | -$58 | -$159 | -$187 | -$196 |
| % Margin | -26.7% | -104% | -181.9% | -3,125.4% |
| Net Income | $1,184 | -$108 | -$142 | -$121 |
| % Margin | 544.5% | -70.4% | -138.6% | -1,929.3% |
| EPS Diluted | 1.2 | -0.11 | -0.145 | -0.124 |
| % Growth | 1,192.9% | 24.3% | -17.3% | – |
| Operating Cash Flow | -$84 | -$191 | -$227 | $631 |
| Capital Expenditures | $0 | -$2 | -$1 | -$3 |
| Free Cash Flow | -$84 | -$193 | -$228 | $628 |